Definitive Healthcare, a healthcare commercial intelligence company headquartered in Framingham, announced on Monday it has filed a registration statement with the U.S. Securities and Exchange Commission, relating to a proposed initial public offering of shares of its Class A common stock.
The company intends to list its Class A common stock under “DH” on the NASDAQ Global Select Market Composite, but the number of offered shares and the price range for the proposed offering have not yet been determined, said the press release from Definitive Healthcare.
New York investment companies Goldman Sachs & Co. LLC and J.P. Morgan Securities Inc are the lead joint bookrunning managers and representatives of the underwriters for the proposed offering.
Definitive Health offers commercial insight for clients in the healthcare industry, and has over 600 employees, according to its website.
